USA stockpiling of remdesivir: How should the world respond?

被引：2

作者：

Dawoud, Dalia ^{[1
]}

Chalkidou, Kalipso ^{[2
,3
]}

Sullivan, Richard ^{[4
]}

Ruiz, Francis J. ^{[5
]}

Adler, Amanda ^{[6
]}

机构：

[1] Cairo Univ, Fac Pharm, Cairo, Egypt

[2] Ctr Global Dev, London, England

[3] Imperial Coll London, Practice Global Hlth, London, England

[4] Kings Coll London, Canc & Global Hlth, London, England

[5] Imperial Coll London, Ctr Global Dev, London, England

[6] Univ Oxford, NICE Technol Appraisal Comm B, Oxford, England

来源：

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2020年 / 9卷 / 18期

关键词：

antiviral; coronavirus; COVID-19; dexamethasone; remdesivir; SARS-CoV-2; stockpiling;

D O I：

10.2217/cer-2020-0174

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms: low-dose dexamethasone and remdesivir. The USA decision to stockpile the latter has resulted in widespread condemnation and in similar action being taken by some other countries. In this commentary we discuss whether stockpiling remdesivir is justified in light of the currently available evidence.

引用

页码：1243 / 1246

页数：4

共 18 条

[11] Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
Onder, Graziano
Rezza, Giovanni
Brusaferro, Silvio
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1775 - 1776
[12] Pan H, 2020, REPURPOSED ANTIVIRAL, DOI 10.1101/2020.10.15.20209817
[13] Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
Rodrigo, C.
Fernando, S. D.
Rajapakse, S.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (08) : 979 - 987
[14] Senanayake SL, 2020, FUTURE DRUG DISCOV, V2, DOI 10.4155/fdd-2020-0010
[15] Shah HA, 2020, DEXAMETHASONE SEVERE
[16] Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, Reed A. C.
Bartoszko, Jessica J.
Ge, Long
Zeraatkar, Dena
Izcovich, Ariel
Pardo-Hernandez, Hector
Rochwerg, Bram
Lamontagne, Francois
Han, Mi Ah
Kum, Elena
Liu, Qin
Agarwal, Arnav
Agoritsas, Thomas
Alexander, Paul
Chu, Derek K.
Couban, Rachel
Darzi, Andrea
Devji, Tahira
Fang, Bo
Fang, Carmen
Flottorp, Signe Agnes
Foroutan, Farid
Heels-Ansdell, Diane
Honarmand, Kimia
Hou, Liangying
Hou, Xiaorong
Ibrahim, Quazi
Loeb, Mark
Marcucci, Maura
McLeod, Shelley L.
Motaghi, Sharhzad
Murthy, Srinivas
Mustafa, Reem A.
Neary, John D.
Qasim, Anila
Rada, Gabriel
Bin Riaz, Irbaz
Sadeghirad, Behnam
Sekercioglu, Nigar
Sheng, Lulu
Switzer, Charlotte
Tendal, Britta
Thabane, Lehana
Tomlinson, George
Turner, Tari
Vandvik, Per O.
Vernooij, Robin Wm
Viteri-Garcia, Andres
Wang, Ying
Yao, Liang
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
[17] Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Wang, Yeming
Zhang, Dingyu
Du, Guanhua
Du, Ronghui
Zhao, Jianping
Jin, Yang
Fu, Shouzhi
Gao, Ling
Cheng, Zhenshun
Lu, Qiaofa
Hu, Yi
Luo, Guangwei
Wang, Ke
Lu, Yang
Li, Huadong
Wang, Shuzhen
Ruan, Shunan
Yang, Chengqing
Mei, Chunlin
Wang, Yi
Ding, Dan
Wu, Feng
Tang, Xin
Ye, Xianzhi
Ye, Yingchun
Liu, Bing
Yang, Jie
Yin, Wen
Wang, Aili
Fan, Guohui
Zhou, Fei
Liu, Zhibo
Gu, Xiaoying
Xu, Jiuyang
Shang, Lianhan
Zhang, Yi
Cao, Lianjun
Guo, Tingting
Wan, Yan
Qin, Hong
Jiang, Yushen
Jaki, Thomas
Hayden, Frederick G.
Horby, Peter W.
Cao, Bin
Wang, Chen
[J]. LANCET, 2020, 395 (10236) : 1569 - 1578
[18] Whittington, 2020, ALTERNATIVE PRICING

← 1 2 →